Tumor load and percentage of PCs in BM and PB after treatment
| Samples . | BM postInd3 MRD-positive samples only (n = 29) MRD cutoff 1 × 10−5 . | PB postInd3 MRD-positive samples only (n = 6) MRD cutoff 1 × 10−6 . | ||
|---|---|---|---|---|
| Variable | Aberrant PCs (%) | Tumor load | Aberrant PCs (%) | Tumor load |
| Minimum | 0 | 2.50E-06 | 0.001 | 1.21E-05 |
| Median | 0.037 | 3.76E-04 | 0.003 | 2.92E-05 |
| Maximum | 8.500 | 8.31E-02 | 6.800 | 7.87E-02 |
| Variable | Normal PCs (%) | Overall PCs (%) | Normal PCs (%) | Overall PCs (%) |
| Minimum | 0 | 0.003 | 0.001 | 0.003 |
| Median | 0.016 | 0.045 | 0.005 | 0.008 |
| Maximum | 0.140 | 8.600 | 0.050 | 6.850 |
| Samples . | BM postInd3 MRD-positive samples only (n = 29) MRD cutoff 1 × 10−5 . | PB postInd3 MRD-positive samples only (n = 6) MRD cutoff 1 × 10−6 . | ||
|---|---|---|---|---|
| Variable | Aberrant PCs (%) | Tumor load | Aberrant PCs (%) | Tumor load |
| Minimum | 0 | 2.50E-06 | 0.001 | 1.21E-05 |
| Median | 0.037 | 3.76E-04 | 0.003 | 2.92E-05 |
| Maximum | 8.500 | 8.31E-02 | 6.800 | 7.87E-02 |
| Variable | Normal PCs (%) | Overall PCs (%) | Normal PCs (%) | Overall PCs (%) |
| Minimum | 0 | 0.003 | 0.001 | 0.003 |
| Median | 0.016 | 0.045 | 0.005 | 0.008 |
| Maximum | 0.140 | 8.600 | 0.050 | 6.850 |
BM, bone marrow; MRD, measurable residual disease; PB, peripheral blood; PCs, plasma cells; postInd3, after 3 cycles of induction therapy.